Business Description
InfuSystems Holdings Inc
NAICS : 339112
SIC : 3841
Description
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | 0.53 | |||||
| Debt-to-Equity | 0.59 | |||||
| Debt-to-EBITDA | 1.86 | |||||
| Interest Coverage | 2.88 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 2.94 | |||||
| Beneish M-Score | -3.1 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9 | |||||
| 3-Year EBITDA Growth Rate | -10.1 | |||||
| 3-Year EPS without NRI Growth Rate | -63.2 | |||||
| 3-Year FCF Growth Rate | -68.2 | |||||
| 3-Year Book Growth Rate | 7.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 118.51 | |||||
| Future 3-5Y Total Revenue Growth Rate | 8.32 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 14.06 | |||||
| 9-Day RSI | 27.46 | |||||
| 14-Day RSI | 38.5 | |||||
| 6-1 Month Momentum % | 42.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.98 | |||||
| Quick Ratio | 1.59 | |||||
| Cash Ratio | 0.02 | |||||
| Days Inventory | 36.89 | |||||
| Days Sales Outstanding | 57.13 | |||||
| Days Payable | 50.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.5 | |||||
| Shareholder Yield % | 2.53 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 51.89 | |||||
| Operating Margin % | 4.16 | |||||
| Net Margin % | 1.12 | |||||
| FCF Margin % | 1.72 | |||||
| ROE % | 2.8 | |||||
| ROA % | 1.42 | |||||
| ROIC % | 2.44 | |||||
| ROC (Joel Greenblatt) % | 8.92 | |||||
| ROCE % | 6.13 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 129.37 | |||||
| Forward PE Ratio | 29.07 | |||||
| PE Ratio without NRI | 129.37 | |||||
| Shiller PE Ratio | 345.2 | |||||
| Price-to-Owner-Earnings | 1630 | |||||
| PEG Ratio | 40.43 | |||||
| PS Ratio | 1.32 | |||||
| PB Ratio | 3.12 | |||||
| Price-to-Tangible-Book | 3.85 | |||||
| Price-to-Free-Cash-Flow | 72.77 | |||||
| Price-to-Operating-Cash-Flow | 10.28 | |||||
| EV-to-EBIT | 38.05 | |||||
| EV-to-EBITDA | 11.72 | |||||
| EV-to-Revenue | 1.56 | |||||
| EV-to-FCF | 84.89 | |||||
| Price-to-Projected-FCF | 4.05 | |||||
| Price-to-Median-PS-Value | 0.97 | |||||
| Price-to-Graham-Number | 4.69 | |||||
| Earnings Yield (Greenblatt) % | 2.63 | |||||
| FCF Yield % | 1.44 | |||||
| Forward Rate of Return (Yacktman) % | 0.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
InfuSystems Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 121.697 | ||
| EPS (TTM) (€) | 0.057 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 38.5 | ||
| 14-Day ATR (€) | 0.228411 | ||
| 20-Day SMA (€) | 8.325 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 5.2 - 9 | ||
| Shares Outstanding (Mil) | 21.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
InfuSystems Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
InfuSystems Holdings Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
InfuSystems Holdings Inc Frequently Asked Questions
What is InfuSystems Holdings Inc(STU:1TZ)'s stock price today?
The current price of STU:1TZ is €7.50. The 52 week high of STU:1TZ is €9.00 and 52 week low is €5.20.
When is next earnings date of InfuSystems Holdings Inc(STU:1TZ)?
The next earnings date of InfuSystems Holdings Inc(STU:1TZ) is 2025-03-14 Est..
Does InfuSystems Holdings Inc(STU:1TZ) pay dividends? If so, how much?
InfuSystems Holdings Inc(STU:1TZ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers